Commentary/Response Threads
- Nanchahal, J, Ball, C, Swettenham, J, Dutton, S, Barber, V, Black, J, Copsey, B, Dritsaki, M, Taylor, P, Gray, A, Feldmann, M and Lamb, S Study protocol: A multi-centre, double blind, randomised, placebo-controlled, parallel group, phase II trial (RIDD) to determine the efficacy of intra-nodular injection of anti-TNF to control disease progression in early Dupuytren’s disease, with an embedded dose response study. [version 1; peer review: 1 approved, 1 approved with reservations]. (deposited 11 Feb 2020 12:25)